SK Biopharm Attracts 570 Trillion Won in Institutional Demand Forecast
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020061916023615234_1592550156.jpg)
[Asia Economy Reporter Park Jihwan] SK Biopharm attracted approximately 570 trillion won in funds during the two-day domestic institutional demand forecast held on the 17th and 18th.
According to the financial investment industry on the 19th, a total of 976 institutions participated in SK Biopharm's domestic institutional investor demand forecast. The total funds participating in the demand forecast reached 569.7628 trillion won.
Their average participation price was 58,617 won, exceeding the upper limit of the public offering price range (36,000 won to 49,000 won). SK Biopharm allocated 11,746,986 shares, which is 80% of the general public offering, to institutional investors in this offering. It plans to raise a total of 575.6 billion won (based on the upper limit of the public offering price).
SK Biopharm is considered the biggest IPO in this year's market. Its corporate value is expected to reach around 4 trillion won.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
Based on the demand forecast results, SK Biopharm will finalize the public offering price today. General investor subscription will take place on the 23rd and 24th.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
